David Tyrrell
Directeur/Membre du Conseil chez BURCON NUTRASCIENCE CORPORATION
Fortune : - $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Peter Kappel | M | - | 8 ans | |
| Ian Ihnatowycz | M | 71 | 11 ans | |
| Dorothy Law | F | 54 | 26 ans | |
| Laine M. Woollard | M | - |
University of Alberta
| 38 ans |
| Shong Tak Tam | M | 61 |
University of Alberta
| 9 ans |
| John Ferguson | M | 82 |
University of Alberta
| - |
| Pamela Fralick | F | - |
Health Research Foundation
| - |
| Robert Thirsk | M | - |
Canadian Institutes of Health Research
 Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | 12 ans |
| Jason Dyck | M | - |
University of Alberta
| 29 ans |
| Alfred Lau | M | - | 3 ans | |
| Jeanne McCaherty | F | - | 3 ans | |
| Debora Fang | F | - | 4 ans | |
| Gordon Panas | M | - |
University of Alberta
| 5 ans |
| Lawrence Jardine | M | - |
Canadian Institutes of Health Research
Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | - |
| Charlene Butler | F | - |
University of Alberta
| - |
| Allen Amyotte | M | - |
University of Alberta
| - |
| Linda Hughes | F | 73 |
University of Alberta
| 16 ans |
| Cheryl Earle | F | - |
University of Alberta
| - |
| Roderick D. Fraser | M | 83 |
University of Alberta
| 29 ans |
| Jade Cheng | F | - | 13 ans | |
| Borys Chabursky | M | - | 9 ans | |
| Gordon James Clanachan | M | - |
University of Alberta
| - |
| Michael Houghton | M | 73 |
Li Ka Shing Institute of Virology
 Li Ka Shing Institute of Virology Miscellaneous Commercial ServicesCommercial Services Li Ka Shing Institute of Virology supports discoveries in vaccines, treatments, and diagnostic tests for viral diseases affecting humans. Its technology platforms include ribonucleic acid interface screening core, flow cytometry, and microscopy. The company was founded in April 2010 and is headquartered in Edmonton, Canada.
University of Alberta
| 14 ans |
| Todd Werre | M | - |
University of Alberta
| - |
| Ben Louie | M | - |
University of Alberta
| - |
| Rob Pawliuk | M | - |
University of Alberta
| - |
| Jennifer Jennax | F | - |
University of Alberta
| - |
| Kirk MacLeod | M | - |
University of Alberta
| - |
| Geoff Rode | M | - |
University of Alberta
| - |
| Fatima Mirza | F | - |
University of Alberta
| - |
| Chad Schulz | M | - |
University of Alberta
| - |
| Rob Parks | M | - |
University of Alberta
| - |
| Joyce Hiller | F | - |
University of Alberta
| - |
| Doug Wylie | M | - |
University of Alberta
| - |
| James Hole | M | 80 |
University of Alberta
| 21 ans |
| Glenn Stowkowy | M | - |
University of Alberta
| - |
| Randy Goebel | M | - |
University of Alberta
| - |
| Matthew Brown | M | - |
University of Alberta
| - |
| T. Alex McPherson | M | 85 |
University of Alberta
| - |
| Mona Hale | F | - |
University of Alberta
| - |
| Ray Muzyka | M | - |
University of Alberta
| 11 ans |
| David Wishart | M | - |
University of Alberta
| 39 ans |
| Raimar Löbenberg | M | 58 |
University of Alberta
| 24 ans |
| Paul Lam | M | - | - | |
| Mark Cormier | M | - |
University of Alberta
| - |
| W. Michael Gallatin | M | - |
University of Alberta
| - |
| Peter Silverstone | M | - |
University of Alberta
| 32 ans |
| Peter C. Flynn | M | - |
University of Alberta
| - |
| Benoit Rivard | M | - |
University of Alberta
| - |
| Chia-Huang Lawerence Wang | M | - |
University of Alberta
| 19 ans |
| Rick Chalaturnyk | M | - |
University of Alberta
| 27 ans |
| Elan MacDonald | F | - |
University of Alberta
| 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Johann Franz Tergesen | M | - | 24 ans | |
| Norman Miles Kneteman | M | - |
KMT Hepatech, Inc.
 KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services KMT Hepatech, Inc. provides vivo research services focusing on preclinical development of Hepatitis C, Hepatitis B, and Malaria therapeutics and vaccines. It offers scientific evaluation services for drug metabolism, lipoprotein metabolism, dose response, and drug treatment. The firm provides KMT Mouse, a transgenic mouse model for practical testing of HCV drug candidates. The company was founded by Norman Miles Kneteman, David F. Mercer and David Lorne John Tyrrell in 2001 and is headquartered in Edmonton, Canada. | - |
| Ron Ritter | M | - |
University of Alberta
| 14 ans |
| Bill James Peck | M | 64 |
University of Alberta
| - |
| Bruce D. Brydon | M | - | 6 ans | |
| Craig Wilson | M | 52 |
University of Alberta
| 9 ans |
| Douglas Owen Goss | M | - |
University of Alberta
| 11 ans |
| Kenneth Howling | M | 66 | 4 ans | |
| John Gilpin | M | - |
ViRexx Medical Corp.
 ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | 17 ans |
| Vanessa Avila | F | 47 |
University of Alberta
| 6 ans |
| Dale Hildebrand | M | 60 |
University of Alberta
| 7 ans |
| Doug McMillan | M | - |
University of Alberta
| 7 ans |
| Michael Brown | M | 52 |
University of Alberta
| 7 ans |
| Michèle Stanners | F | 66 |
University of Alberta
| 3 ans |
| Louis Hugo Francescutti | M | - |
University of Alberta
| 5 ans |
| Chad Robinson | M | - |
University of Alberta
| - |
| Ronald Kisic | M | - |
University of Alberta
| 8 ans |
| Travis Murdoch | M | - |
University of Alberta
| 9 ans |
| Scott Rempel | M | - |
University of Alberta
| 7 ans |
| Arden Tse | M | - |
University of Alberta
| 2 ans |
| Robert Mccue | M | - |
University of Alberta
| 3 ans |
| Chelsea Stellick | F | - |
University of Alberta
| 7 ans |
| Yasmine AI Hussein | F | - |
University of Alberta
| 8 ans |
| Lorna Harron | F | - |
University of Alberta
| 6 ans |
| Dean Mullin | M | - |
University of Alberta
| 5 ans |
| Mike H. Gilchrist | M | - |
University of Alberta
| 6 ans |
| Keith Diakiw | M | 51 |
University of Alberta
| 5 ans |
| Marty Proctor | M | 63 |
University of Alberta
| 5 ans |
| Chuen Hing Cheung | M | - |
University of Alberta
| 3 ans |
| Melvin Benson | M | 75 |
University of Alberta
| - |
| Ralph B. Young | M | 78 |
University of Alberta
| 4 ans |
| Linnea Marie McKercher | F | - |
University of Alberta
| 7 ans |
| Kevin J. Brown | M | 62 |
University of Alberta
| 6 ans |
| Andrea Hatzinikolas | F | - |
University of Alberta
| 8 ans |
| Kevin Yakiwchuk | M | - |
University of Alberta
| 6 ans |
| George Chow | M | 62 |
University of Alberta
| 8 ans |
| R. Allford | M | - |
University of Alberta
| 8 ans |
| Jay P. Reid | M | 60 |
University of Alberta
| 7 ans |
| Vladislav C. Vlad | M | - |
University of Alberta
| 8 ans |
| Stephen H. Johnston | M | - |
University of Alberta
| 7 ans |
| Donald Boykiw | M | - |
University of Alberta
| 7 ans |
| Miles W. Safranovich | M | - |
University of Alberta
| 9 ans |
| Raymond Bower | M | - |
University of Alberta
| 4 ans |
| Macaraig Canton | M | - |
ViRexx Medical Corp.
ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | 2 ans |
| Christian Bayle | M | 55 |
University of Alberta
| 5 ans |
| Terry Sydoryk | M | - |
University of Alberta
| 8 ans |
| Kevin R. Mather | M | 51 |
University of Alberta
| 6 ans |
| Bassam El-Fahmawi | M | - |
University of Alberta
| 6 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Canada | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- David Tyrrell
- Réseau Personnel
